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SUMMARY KEYWORDS
Aside from motor and cognitive deficits,
Parkinson patients also manifest a little-studied
olfactory deficit. Since in Parkinson’s disease
there is a dopamine depletion of the amygdala
due to mesocorticolimbic system degeneration,
we decided to test olfactory and taste
performance of 6-OHDA amygdala lesioned
rats, as well as the possible restoration of either
function with adrenal medullary transplants.
Two 6-OHDA lesioned groups and one
control group were tested in the potentiation of
odor by taste aversion paradigm. On taste
aversion none of the groups showed any
impairment. In contrast, the 6-OHDA lesioned
rats showed a marked impairment in olfactory
aversion. At this point, one of the lesioned
groups received a bilateral adrenal medullary
graft within the lesioned area. After two months,
all groups were submitted again to the
behavioral paradigm. Taste remained
unaffected, but the lesioned only group did not
recover either olfactory aversion or normal
catecholamine levels. The grafted group, on the
other hand, restored olfactory aversion and
catecholamine levels. It can be concluded from
this study that catecholamine depletion of the
amygdala is sufficient to produce a selective
olfactory deficit, not accompanied by taste
impairments, and that such a deficit can be
reversed by adrenal medullary transplants,
which in turn restore catecholamine levels.
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INTRODUCTION
The main dopamine (DA) innervation to the
telencephalon is provided by the mesencephalic
DAergic system which is divided into two main
subsystems, the mesostriatal cell group (MS)
projecting to the striatum /7,11,48/, and the
mesocorticolimbic cell group (MCL), projecting to
the limbic system and the cortex/7,15,23/.
The mesencephalic projections to the striatum
have been widely studied in rodents and have
provided a useful model for the study of motor
impairments in Parkinson’s disease (PD)/66,67,70/.
As such, the unilateral DA depletion of the rat
striatum, which produces motor deficits
characterized by circling behavior/5,6,20,53/, has
been shown to be alleviated by transplantation of
DA-rich cells /6,7,20,51/. Based on the animal
studies mentioned above, alleviation of the
symptoms of PD have been observed in some
patients subjected to transplantation of dopamine
producing cells from the adrenal medulla or from
embryonic substantia nigra/19,29,30,33,43,45,62/.
In addition to motor deficits, PD patients also
have cognitive deficits/10,12,42/. These symptoms
have been ascribed partially to the second main
DAergic subsystem /36,57,58,69/. The cognitive
deficits seen in PD patients are similar to those seen
in frontal lobe patients when these deficits are
measured with the Wisconsin Card Sorting Test
/41/, which is the critical probe for prefrontal
subjects /46,47,65/. Since these cognitive deficits
VOLUME 4, NO. 4, 1993 28929O J. FERNIIDEZ-RUIZ ET AL.
have also been allcviatexi in transplanted PD patients
/50/, the role ofDA in these deficits may be critical.
Additional support for DA involvement in the
cognitive deficits comes from post-mortem studies
of PD patients which demonstrate severe
degeneration of the MCL dopaminergic system
/38,59/ and from studies showing that DA
disruption of the preontal cortex of monkeys
impairs a delayed non-matching to sample task
/9,56/, while depletion of the MCL DA-system in
the rat produces impairments in alternation tasks
/60/.
A little studied non-motor disturbance of PD
patients is reflected in a deficit in olfactory
discrimination or recognition tasks /1,13,16,17,39,
68/. Although the neuronal basis of this olfactory
deficit has not been established, a candidate
structure could be the amygdala, since DAergic
innervation from the MCL system to the amygdala
/22,24,49/ is severely affected in PD subjects
/37,59/. Moreover, aside om receiving DAergie
innervation, the amygdala, which in addition
receives an olfactory input from the pyriform cortex
/63/, has been shown to be involved in different
olfactory learning tasks/2,31/.
Therefore, the purpose of the present
experiments was to determine whether adrenal
medullary grafts could restore catecholamine levels
and olfactory deficits in 6-OHDA amygdala
lesioned rats, in order to have an animal model for
the study of the olfactory dysfunction seen in
Parkinson’s disease.
MATERIALS AND METHODS
Subjects
Subjects were 24 male Wistar rats, weighing
250 g at the beginning of the experiment. The rats
were housed under standard laboratory conditions
with food and water ad libitum, unless otherwise
indicated. The lights were automatically turned on
at 8:00 and turned off at 20:00 h.
The subjects were randomly assigned to one of
three groups of eight rats each: 1. Control group
(NON-LESIoNED GROUP) (n=8) which received
sham lesions only; 2. amygdala lesioned group
(LESIONED + SHAM GRAFT) (n=8), which two
months after receiving 6-OHDA bilateral lesions in
the amygdala, received sham transplants; 3. adrenal
medullary transplant group (LESIONED + AM
GRAb’T) (n=8) which, after the first behavioral test
(to be described), received bilateral adrenal
medullary transplants into the previously 6-OHDA
lesioned amygdala.
Surgery
Animals were deeply anesthetized with
halothane for stereotaxic surgery. Two of the
groups received bilateral injections of 4 txg of 6-
OHDA dissolved in 0.5 ixl of saline solution 0.9%.
The following coordinates according to Paxinos’
and Watson’s stereotaxic atlas of the rat/52/were
used for the amygdala lesion (n=8): A-P: -2.2; L:
4.5; H: -7.5; Control animals (n=8) were given
vehicle injections in the same coordinates. The
injections were administered with a 1 ixl Hamilton
syringe at a rate of 0.5 lal in five minutes. Injector
needles were left in place at each injection site for
five additional minutes. Subjects were allowed to
recover for 7 days with food and water ad libitum.
Behavioral paradigm
To evaluate olfactory learning, we used the
potentiation of odor aversion by taste paradigm
(POAT)/51/. We chose this paradigm because it is
sensitive to amygdaloid lesions, it only requires one
single session of acquisition of the learning task and
enables us to compare the olfactory versus the taste
learning in the same animal in order to discard a
general learning deficit /2,35,51/. All the POAT
procedures were carried out in 30x45x20 cm clear
plastic cages. The tops of the cages were fitted with
holes which provided access to two 50 ml test tubes
with stainless steel drinking spouts fitted with a
filter paper disk around the drinking spout. The
filter paper disk consisted of a 1 cm2 piece of filter
paper scented with 0.1 ml of the odor scent only
when indicated. The test tubes which were
alternated every day from side to side contained
water except in the acquisition and taste trials. The
total volume of liquid consumed from the taste
tubes was recorded daily as a baseline consumption
measure.
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Pre-transplant tests
After the recovery period the subjects were
habituated during 30 minutes to the experimental
apparatus. Then, the animals were restricted to a
drinking schedule in which water was available in
two bottles twice a day, once for ten min each
morning (10:00) and again for ten min each
afternoon (17:00). After the animals reached a
stable base-line of water consumption (5 days), all
rats received in the morning a presentation of a
neutral odor (peach) in the odor disk, while drinking
water in a single test tube. After two more days of
base-line water consumption, all rats received in the
morning period a single acquisition trial, which
consisted of the presentation of an odor (almond)
paired with sodium saccharin dissolved in distilled
water (0.1%) instead of water alone. Thirty min
after the presentation of the compound, a 0.4 M
LiCl intraperitoneal injection (1 ml/100 g) was
given to all subjects. After the conditioning trial,
subjects received both periods of water
consumption on 3 consecutive days to reestablish
base-line drinking. Then, the animals were tested for
each of the components of the flavor. The odor and
taste were tested alternately, taste and odor being
counterbalanced within groups.
Odor behavioral test
The odor test consisted of water in both test
tubes with almond in one odor disk versus peach in
the other one. The odor test procedures were given
until three extinction tests were completed.
Taste behavioral test
The taste test consisted of saccharin solution in
one test tube and water alone in the other test tube.
The taste test procedures were given until three
extinction tests were completed.
Transplant procedure
After the first behavioral testing was completed,
eight of the previously lesioned rats (LESIONED +
AM GRAFT group) were submitted to the
transplant procedure, which consisted of placing
two solid adrenal medullas, taken from newborn
rats, into the site of each of the previously lesioned
amygdala. The transplants were made using a 100 Ix
Hamilton (gas-tight) syringe. The injection of each
solid medullary fragment was aided by adding a
0.9% saline solution whose volume varied between
3 and 10 txl. Half of the LESIONED + SHAM
GRAFT animals received sham transplants, which
consisted of the injection of 10 ixl of vehicle alone in
each of the previously lesioned amygdala. After
completion of all surgical procedures the rats were
allowed to recover for two months.
Post-transplant tests
After the recovery period, all groups were
submitted to the same behavioral procedure as
described above, i.e., acquisition ofPOAT and three
extinction trials for odor and taste counterbalanced.
Tissue monoamine level measurements
After all the behavioral tests were finished, the
rats were decapitated and the brains were rapidly
removed and dissected on ice as follows. With the
help of a chopper the brains were cut into 2 mm
wide slices. The amygdala nuclei were obtained
from the slices with the help of a punch 1.8 mm in
diameter. After the dissection procedure the
amygdala nuclei of both hemispheres were weighed
and homogenized together on ice in 100-200 lal of
0.4M perchloric acid containing known amounts of
dihydroxybenzylamine (DHBA). All the samples
were centrifuged at 12,000 rpm for 15 min.
Supernatants from the samples were filtered
through Millipore 5JHV 0.45 lam. Aliquots of 20
of the filtered samples were injected into the HPLC
system.
Chromatograph measurements were carried out
using a Beckman System Gold chromatograph and
a reversed-phase Ultrasphere Ion Pair C18 column
(200 x 4.6 mm I.D.). The column eluent was
monitored with an electrochemical detector Model
LC-4 and a glassy carbon electrode from
Bioanalytical Systems LC4. The detector potential
was +0.75 V vs an Ag/AgCI reference electrode.
The flow-rate was maintained at 1.7 ml/min. The
mobile phase was 32% acetonitrile and 68% 10 mM
potassium phosphate (NaH2PO4) 40 mM sodium
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lauryl sulfonate, and 0.5 mM EDTA. Water was
deionized and, like the buffer and acetonitrile, was
filtered through Millipore GS 0.22 Ixm. The column
was used at room temperature. All catecholamine
values were calculated on the basis of an external
standard and expressed as ng/g wet weight tissue
/32/.
Behavioral analysis
All data analyses were performed using the
Aversion Index (AI) using the following formula:
A/(A+B). In the taste test ’A’ was the consumption
of saccharin and ’B’ the consumption of water. In
the odor test ’A’ was water consumption in the
presence of almond, and ’B’ was water
consumption in the presence of peach. With this
formula, therefore, an AI of 0.1 would indicate a
strong aversion, while an AI of 0.9 would suggest a
strong preference for that compound.
Data from the odor and taste tests were
evaluated using a simple analysis of variance
(ANOVA) with post hoe comparisons (Sheff6) to
evaluate the main effects and interactions among
groups. F and p values are given only when
significant, i.e. p<0.05.
Taste behavior
RESULTS
In the first behavioral procedure the control
group showed strong taste aversions (AI 0.12,
0.13 and 0.09) (see Figure 1). Both 6-OHDA
amygdala lesioned groups also showed strong taste
aversions (AI 0.9, 0.10 and 0.14, and AI 0.05,
0.07 and 0.09, respectively).
Two months after the graft procedure, in the
second behavioral test (see Figure 1), the control
and both LESIONED + SHAM GRAFF and
LESIONED + AM GRAFT groups still maintained
strong taste aversions (AI 0.16, 0.19 and 0.24; AI
0.12, 0.15, 0.16; and AI 0.15, 0.14 and 0.18,
respectively).
Odor behavior
In the post-lesion tests there were significant
differences among groups (F(2,21) 19.1, 7.6, and
6.8 for the three test trials, respectively) (p<0.01).
The control group showed a strong odor aversion
(AI 0.17, 0.23 and 0.27), while both 6-OHDA
amygdala lesioned groups showed significantly
disrupted POAT (AI 0.46, 0.47 and 0.49, and AI
0.61, 0.48 and 0.50, respectively) (p<0.01 as
compared with the control group) (Figure 2).
In the behavioral test, after fetal brain grafts, the
control group still showed strong odor aversion (AI
0.07, 0.19 and 0.25). The LESIONED + SHAM
GRAFT group had disrupted odor aversion even
with two acquisition sessions (AI 0.47, 0.5 and
0.52) (p<0.01). The LESIONED + AM GRAFt
group showed a strong odor aversion (AI 0.09,
0.13 and 0.24) to the almond scented test tubes and
was no different from the control group.
Tissue monoamine level measurements
The HPLC results showed a significant
difference between groups for DA [F(2,21) 70.0]
and NE [F(2,21) 4.6] measurements (p<0.05).
The LESIONED + SHAM GRAFT group showed a
significant decrease of DA (91.7%) and NE
(79.8%) with respect to control (p<0.05) (Table 1).
The LESIONED +AM GRAFT showed a complete
recovery of DA levels, which were even slightly
higher (110.5%). The NE content of this group,
though not significantly different from controls, was
only 48.3% of the control level. The 5-HT levels
were not significantly different among the three
groups.
DISCUSSION
The main conclusion obtained from these
experiments is that catecholamine depletion of the
amygdala is sufficient to produce a selective
olfactory deficit, not accompanied by taste
impairment, and that such a deficit can be reversed
by adrenal medullary transplants, which in turn
restore catecholamine levels. Although the specific
mechanism by which the adrenal medulla transplants
induced the behavioral restoration is not known, it
seems that it is not due to the surgical procedure,
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Taste tests. Left side: Taste aversion effect of 6-OHDA injections in the amygdala of two groups (LESIONED + AM
GRAFF and LESIONED + SHAM GRAFI). Right side: Behavioral effect of adrenal medullary transplant in one of the
previously lesioned groups (LESIONED + AM GRAFT). NON-LESIONED GROUP -A-, Control; LESIONED +
SHAM GRAFT .r’l., amygdala lesioned group; LESIONED + AM GRAFT -O-, amygdala lesioned group with
adrenal medullary transplant after the first behavioral test. Aversion Index water consumption of saccharine
containing test tube / total water consumption. *=p<0.05. Note the performance similarity of the three groups both pre-
and post-transplant.
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Odor tests. Left side: POAT effect of6-OHDA injections in the amygdala of two groups (LESIONED + SHAM GRAFT
and LESIONED + AM GRAF13. Right side: Behavioral effect of adrenal medullary transplant in one of the previously
lesioned groups (LESIONED + AM GRAFI). NON-LESIoNED GROUP -A-, control; LESIONED + SHAM GRAFT
-El-, amygdala lesioned group; LESIONED + AM GRAb -O-, amygdala lesioned group with adrenal medullary
transplant after the first behavioral test. Aversion Index water consumption of almond scented test tube / total water
consumption. *=p<0.05. Note the reduction of Aversion Index in the LESIONED + AM GRAFT group after the adrenal
medullary transplant.
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TABLE 1
Monoamine levels in amygdala of non-lesioned, LESIONED + SHAM GRAFT and LESIONED +AM GRAFT groups
(n=8 per group)
NE DA 5-HT
NON-LESIONED GROUP
LESIONED + SHAM GRAVI’
LESIONED +AM GRAFT
462.7 +/- 132.5 151.8 +/- 46.0 216.0 +/- 55.9
93.6 +/- 31.3" 12.6 +/- 8.6* 364.5 +/- 78.1
223.8 +/- 32.0 167.8 +/- 22.6 302.0 +/- 38.5
Results are given as ng/g tissue (wet weight), mean +/- SEM.
*p<0.05, comparison of the values found in the amygdala lesioned, adrenal medullary transplanted and control groups by an
ANOVA simple analysis of variance, and a post hoc comparison (Shelf6) to evaluate the effects and interactions.
since the sham transplant procedure did not restore
the behavior. It is also unlikely that tissue
implantation alone produced the behavioral effect,
since it has been shown that there is no behavioral
difference between sham and sciatic nerve control
subjects/64/. In addition, it could be suggested that
this animal model may be an appropriate one for
studying the olfactory deficits seen in PD patients.
Interestingly, the deficiency in olfactory
discrimination or recognition seen in idiopathic PD
is not shared by 1-methyl-4-phenyl-l,2,5,6-
tctrahydropyridinc (MPTP) or by supranuclcar palsy
patients (SPN), even though they have similar
motor disturbances. One of the differences between
PD and MPTP or SPN patients is that in the last
two, there is no significant lesion of the MCL
system, while there is significant damage to that
pathway in PD /14,18,55/. Should the olfactory
deficit in PD bc specifically related to MCL
damage, the reason the other two groups of patients
do not have the olfactory dysfunction can be easily
understood/18/.
The nature of the olfactory deficit in 6-OHDA
lesioned amygdala rats is not related to a general
learning deficit, since the taste aversion was well
acquired by both groups of lesioned rats; therefore,
the alteration seems to be related to a specific
deficit in the acquisition of the olfactory modality of
the POAT. Although in rodents it is difficult to
differentiate among the various components of this
behavior, it can be argued that the deficit is not
related to an olfactory sensory disruption, since
there is evidence suggesting that amygdala lesioned
rats are not anosmic/2,31/. The same can be argued
in relation to the cognitive aspects of the deficit
produced by amygdala lesions, since they do not
produce a general non-specific effect; i.e., the taste
aversion remained unaltered. Moreover, this specific
effect can be reversed by adrenal medulla
transplants, results that are compatible with
previous reports on the effects of brain transplants
on different cognitive tasks /3,26,40,61/. One of
these tasks is the conditioned taste aversion
paradigm, in which fetal insular cortex transplants
to lesioned rats can restore taste aversion
/3,21,25,44/. Previous findings in the study of
conditioned taste aversion and POAT suggest that
different structures are involved in the acquisition
process of taste and odor aversions. While it is clear
that the insular cortex is highly involved in the
acquisition of taste aversion, the odor aversion
acquisition seems to depend on structures like the
amygdala or the hippocampus, and not on the
insular cortex or the dorsal striatum /4/. It thus
appears clear that olfactory and taste functions
depend on different brain structures.
The present results suggest that the 6-OHDA
lesion of the amygdala affects olfactory but not taste
aversion, a deficit which was reversed by adrenal
medullary transplants. It remains to be determined
whether the olfactory deficits of this animal model
are linked to the olfactory incapacity seen in
Parkinson’s disease patients.
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